Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PostbiotiX
- Development stage
- Unknown
- Lead developer
- Postbiotica
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
PostbiotiX is a line of dietary supplements developed by Postbiotica using its proprietary PBTech® fermentation technology. The line includes several formulations—Restore, Motility, Comfort, Slowing, and Immuno—each designed to address specific aspects of intestinal health or to support the immune system. Unlike probiotics, which contain live bacteria, PostbiotiX products contain postbiotics, which are non-viable bacterial components and metabolic byproducts (such as short-chain fatty acids, enzymes, and peptides) that exert beneficial physiological effects on the host. These supplements are administered orally and are intended to modulate the gut microbiota and enhance the intestinal barrier and immune defense.
- Brand names
- PostbiotiXPostbiotiX RestorePostbiotiX MotilityPostbiotiX ComfortPostbiotiX SlowingPostbiotiX Immuno
02
Targets
PRR (Pattern recognition receptors)
Beyond the preview
Go deeper on PostbiotiX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PostbiotiX.